4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases
May 16, 2023 08:00 ET
|
4Bio Capital
Press Release 4BIO Capital Portfolio Company Ray Therapeutics Closes Oversubscribed $100M Series A Financing to Advance Optogenetic Gene Therapies for Blinding Diseases Series A follows initial seed...
4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics
January 04, 2022 08:04 ET
|
4Bio Capital
Press Release 4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics 4 January 2022 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...
4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics
January 04, 2022 08:03 ET
|
4Bio Capital
Press Release 4BIO Capital Leads $6 Million Seed Financing in Ray Therapeutics 4 January 2022 LONDON & BOSTON – 4BIO Capital (“4BIO” or “the Group”), an international venture capital firm...